Skip to main content

Advertisement

SpringerLink
Log in

Naringin promotes osteoblast differentiation and effectively reverses ovariectomy-associated osteoporosis

  • Original Article
  • Published:
Journal of Orthopaedic Science

Abstract

Background

Osteoporosis is a common pathological condition that influences 20 % of women over 50 years of age. This condition decreases bone strength and increases the risk of bone fracture. Naringin is a major flavonoid found in grapefruit and an active compound extracted from a Chinese herbal medicine (Rhizoma Drynariae). Studies have shown that naringin possesses many pharmacological effects. The current study evaluated the influence of naringin on osteoblastic cell differentiation and proliferation, and assessed its therapeutic effects on a rat osteoporosis model.

Method

The proliferation, differentiation, and function of rat bone marrow stromal cells (BMSCs) were determined following treatment with various concentrations of naringin. Ovariectomy (OVX)-induced osteoporotic rats were orally administered naringin daily at low, medium, and high dosages, while a control group received PBS for 2 months. Femoral X-ray images and microCT scans were used for bone mineral density (BMD) and BV/TV (bone volume/total volume) analyses, and histological assessments of left tibiae were employed to check for changes in trabecular thickness (Tb.Th) and trabecular space (Tb.Sp) in the groups.

Results

Naringin was effective at enhancing the proliferation and osteogenic differentiation of BMSCs, and a concentration of 10 μg/ml prompted the highest levels of osteocalcin expression among the in vitro study groups. There appeared to be a delayed response pattern of BMSCs to the naringin treatment. Naringin also effectively reversed OVX-induced bone loss via increasing BMD, bone volume, and trabecular thickness. The medium dose (300 mg/kg) appeared to be the optimal dosage for delivering satisfactory therapeutic effects.

Conclusion

Naringin promotes the proliferation and differentiation of BMSCs, and increases osteocalcin expression. Naringin also effectively reverses ovariectomy-induced osteoporosis in rats. The study suggests that naringin administration may represent an effective treatment for osteoporosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Melton LJ 3rd, Chrischilles EA, Cooper C, Lane AW, Riggs BL. How many women have osteoporosis? J Bone Miner Res. 2005;20:886–92.

    Article  PubMed  Google Scholar 

  2. Sowers MR, Zheng H, Jannausch ML, McConnell D, Nan B, Harlow S, Randolph JF Jr. Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause. J Clin Endocrinol Metab. 2010;95:2155–62.

    Article  PubMed  CAS  Google Scholar 

  3. Duque G, Troen BR. Understanding the mechanisms of senile osteoporosis: new facts for a major geriatric syndrome. J Am Geriatr Soc. 2008;56:935–41.

    Article  PubMed  Google Scholar 

  4. Ritchie RO, Buehler MJ, Hansma P. Plasticity and toughness in bone. Plasticity and toughness in bone. Phys Today. 2009;62:41–7.

    Article  CAS  Google Scholar 

  5. Zimmermann EA, Schaible E, Bale H, Barth HD, Tang SY, Reichert P, Busse B, Alliston T, Ager JW 3rd, Ritchie RO. Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales. Proc Natl Acad Sci USA. 2011;108:14416–21.

    Article  PubMed  CAS  Google Scholar 

  6. Fitzpatrick P, Kirke PN, Daly L, Van Rooij I, Dinn E, Burke H, Heneghan J, Bourke G, Masterson J. Predictors of first hip fracture and mortality post fracture in older women. Ir J Med Sci. 2001;170:49–53.

    Article  PubMed  CAS  Google Scholar 

  7. Ramesh N, Viswanathan MB, Saraswathy A, Balakrishna K, Brindha P, Lakshmanaperumalsamy P. Phytochemical and antimicrobial studies on Drynaria quercifolia. Fitoterapia. 2001;72:934–6.

    Article  PubMed  CAS  Google Scholar 

  8. Zhang P, Dai KR, Yan SG, Yan WQ, Zhang C, Chen DQ, Xu B, Xu ZW. Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. Eur J Pharmacol. 2009;607:1–5.

    Article  PubMed  CAS  Google Scholar 

  9. Xu Z, Zhang J, Tan G, Zhang P, Chang F. Influence of Rhizoma Drynariae extracted liquid on in vitro osteogenic differentiation of rabbit BMSCs. J Tradit Chin Orthopedics Traumatol (Chin). 2006;18:415–7. (in Chinese).

    Google Scholar 

  10. Kim HJ, Oh GT, Park YB, Lee MK, Seo HJ, Choi MS. Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol fed condition. Life Sci. 2004;74:1621–34.

    Article  PubMed  CAS  Google Scholar 

  11. Bodas R, Prieto N, Lopez-Campos O, Giraldez FJ, Andres S. Naringin and vitamin E influence the oxidative stability and lipid profile of plasma in lambs fed fish oil. Res Vet Sci. 2011;91:98–102.

    Article  PubMed  CAS  Google Scholar 

  12. Pang WY, Wang XL, Mok SK, Lai WP, Chow HK, Leung PC, Yao XS, Wong MS. Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells. Br J Pharmacol. 2010;159:1693–703.

    Article  PubMed  CAS  Google Scholar 

  13. Wei M, Yang Z, Li P, Zhang Y, Sse WC. Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model. Am J Chin Med. 2007;35:663–7.

    Article  PubMed  CAS  Google Scholar 

  14. Yu H, VandeVord PJ, Mao L, Matthew HW, Wooley PH, Yang SY. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization. Biomaterials. 2009;30:508–17.

    Article  PubMed  CAS  Google Scholar 

  15. Yang SY, Zhang K, Bai L, Song Z, Yu H, McQueen DA, Wooley PH. Polymethylmethacrylate and titanium alloy particles activate peripheral monocytes during periprosthetic inflammation and osteolysis. J Orthop Res. 2011;29:781–6.

    Article  PubMed  CAS  Google Scholar 

  16. Wooley PH, Morren R, Andary J, Sud S, Yang SY, Mayton L, Markel D, Sieving A, Nasser S. Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials. 2002;23:517–26.

    Article  PubMed  CAS  Google Scholar 

  17. Croke M, Ross FP, Korhonen M, Williams DA, Zou W, Teitelbaum SL. Rac deletion in osteoclasts causes severe osteopetrosis. J Cell Sci. 2011;124:3811–21.

    Article  PubMed  CAS  Google Scholar 

  18. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker R. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595–610.

    Google Scholar 

  19. Wong RW, Rabie AB. Effect of naringin collagen graft on bone formation. Biomaterials. 2006;27:1824–31.

    Article  PubMed  CAS  Google Scholar 

  20. Wong RW, Rabie AB. Effect of naringin on bone cells. J Orthop Res. 2006;24:2045–50.

    Article  PubMed  CAS  Google Scholar 

  21. Wu JB, Fong YC, Tsai HY, Chen YF, Tsuzuki M, Tang CH. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur J Pharmacol. 2008;588:333–41.

    Article  PubMed  CAS  Google Scholar 

  22. Zhou X, Zhang P, Zhang C, Zhu Z. Promotion of bone formation by naringin in a titanium particle-induced diabetic murine calvarial osteolysis model. J Orthop Res. 2010;28:451–6.

    PubMed  CAS  Google Scholar 

  23. Ang ES, Yang X, Chen H, Liu Q, Zheng MH, Xu J. Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-kappaB and ERK activation. FEBS Lett. 2011;585:2755–62.

    Article  PubMed  CAS  Google Scholar 

  24. Neve A, Corrado A, Cantatore FP. Osteoblast physiology in normal and pathological conditions. Cell Tissue Res. 2011;343:289–302.

    Article  PubMed  CAS  Google Scholar 

  25. Xia K, Xue H, Dong D, Zhu S, Wang J, Zhang Q, Hou L, Chen H, Tao R, Huang Z, Fu Z, Chen YG, Han JD. Identification of the proliferation/differentiation switch in the cellular network of multicellular organisms. PLoS Comput Biol. 2006;2:1482–97.

    Article  CAS  Google Scholar 

  26. Hirata M, Matsumoto C, Takita M, Miyaura C, Inada M. Naringin suppresses osteoclast formation and enhances bone mass in mice. J Health Sci. 2009;55:463–7.

    Article  CAS  Google Scholar 

  27. Guo D, Wang J, Wang X, Luo H, Zhang H, Cao D, Chen L, Huang N. Double directional adjusting estrogenic effect of naringin from Rhizoma drynariae (Gusuibu). J Ethnopharmacol. 2011;138:451–7.

    Article  PubMed  CAS  Google Scholar 

  28. Ali MM, El Kader MA. The influence of naringin on the oxidative state of rats with streptozotocin-induced acute hyperglycaemia. Z Naturforsch C. 2004;59:726–33.

    PubMed  CAS  Google Scholar 

  29. Roach HI, Mehta G, Oreffo RO, Clarke NM, Cooper C. Temporal analysis of rat growth plates: cessation of growth with age despite presence of a physis. J Histochem Cytochem. 2003;51:373–83.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was partially supported by a research grant from Shandong Provincial Natural Science Foundation, China (No. Y2008C147), and research funding from Orthopaedic Research Institute, Via Christi Wichita Hospitals Inc. The authors wish to thank Ms Zheng Song for her technical assistance.

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Orthopedics, Affiliated Hospital to Shandong University of TCM, 16369 Jingshi Road, Jinan, 250014, Shandong, China

    Nianhu Li & Zhanwang Xu

  2. Department of Biological Sciences, Wichita State University, 1845 N. Fairmont Street, Wichita, KS, 67260, USA

    Nianhu Li, Yunpeng Jiang, Paul H. Wooley & Shang-You Yang

  3. Orthopaedic Research Institute, Via Christi Wichita Hospitals - St. Francis, Wichita, KS, USA

    Paul H. Wooley & Shang-You Yang

  4. Shandong University School of Medicine, Jinan, China

    Yunpeng Jiang

Authors
  1. Nianhu Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yunpeng Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul H. Wooley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhanwang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shang-You Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Zhanwang Xu or Shang-You Yang.

About this article

Cite this article

Li, N., Jiang, Y., Wooley, P.H. et al. Naringin promotes osteoblast differentiation and effectively reverses ovariectomy-associated osteoporosis. J Orthop Sci 18, 478–485 (2013). https://doi.org/10.1007/s00776-013-0362-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00776-013-0362-9

Keywords

Search

Navigation